Literature DB >> 25345397

Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue.

Jie Li1, Lixiang Yu2, Zhouting Long1, Yang Li1, Fenglin Cao1.   

Abstract

OBJECTIVE: Clinical reports have shown that adjuvant chemotherapy has a negative impact on perceived cognitive impairment (PCI) of patients with breast cancer; however, evidence concerning the effects of psychological factors such as post-traumatic stress disorder (PTSD) symptoms on PCI is limited, especially in relation to Chinese patients with breast cancer. This research investigated the associations between psychological factors and PCI in Chinese women with breast cancer.
METHODS: In total, 204 women with breast cancer were assessed for PCI, PTSD symptoms, fatigue, anxiety, and depression using self-report measures. Hierarchical linear regression was conducted to investigate the associations between the variables of interest and PCI.
RESULTS: Two hundred and two women were included in the final analysis; two of those originally tested were excluded because of missing data. A univariate analysis showed that PCI was significantly related to education, PTSD symptoms (re-experience, avoidance, and hyperarousal), fatigue, depression, anxiety, and undergoing chemotherapy or radiotherapy. Hierarchical linear regression revealed that PTSD symptoms and fatigue (ΔR(2)  = 0.26, P < 0.001) independently accounted for PCI in Chinese women with breast cancer regardless of age, education level, chemotherapy and radiotherapy. Hyperarousal was the only contributing PTSD symptom to PCI (B = -1.24, SE = 0.33, β = -0.39, P < 0.001).
CONCLUSIONS: Besides chemotherapy, PTSD symptoms, especially hyperarousal, and fatigue are important risk factors for significant PCI and are therefore worthy of further investigation.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  breast cancer; cancer; fatigue; oncology; perceived cognitive impairment; post-traumatic stress disorder

Mesh:

Substances:

Year:  2014        PMID: 25345397     DOI: 10.1002/pon.3710

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  17 in total

Review 1.  Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

Authors:  M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

2.  Perceived stress and its associated demographic-clinical characteristics and positive expectations among Chinese cervical, kidney, and bladder cancer patients.

Authors:  Yi-Long Yang; Meng-Yao Li; Li Liu; Lie Wang
Journal:  Support Care Cancer       Date:  2018-02-05       Impact factor: 3.603

3.  A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases.

Authors:  Victoria Menzies; Debra L Kelly; Gee S Yang; Angela Starkweather; Debra E Lyon
Journal:  Chronic Illn       Date:  2019-03-18

4.  Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.

Authors:  Jennifer R Klemp; Jamie S Myers; Carol J Fabian; Bruce F Kimler; Qamar J Khan; Susan M Sereika; Annette L Stanton
Journal:  Support Care Cancer       Date:  2017-08-28       Impact factor: 3.603

5.  Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Supaksorn Thika; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Cristiano Noto; Rada Ivanova; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

6.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

Review 7.  Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.

Authors:  Ashley Henneghan
Journal:  Support Care Cancer       Date:  2015-09-29       Impact factor: 3.603

8.  In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.

Authors:  Buranee Kanchanatawan; Supaksorn Thika; Sunee Sirivichayakul; André F Carvalho; Michel Geffard; Michael Maes
Journal:  Neurotox Res       Date:  2018-01-29       Impact factor: 3.911

9.  Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults.

Authors:  Jason D Flatt; Julene K Johnson; Stephen E Karpiak; Liz Seidel; Britta Larson; Mark Brennan-Ing
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion.

Authors:  Ashley Henneghan; Alexa Stuifbergen; Heather Becker; Shelli Kesler; Elisabeth King
Journal:  J Cancer Surviv       Date:  2017-11-07       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.